{"disease":{"id":"moderate-to-severe-acute-pain","name":"moderate to severe acute pain","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"suzetrigine","indication_name":"moderate to severe acute pain","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Journavx","generic_name":"SUZETRIGINE","company_name":"Vertex Pharms Inc","drug_phase":"marketed","molecular_target":"","drug_class":"Sodium Channel Blocker [EPC]","quality_score":65,"revenue":null,"mechanism":"Journavx blocks sodium channels in the nervous system to reduce pain signal transmission."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02662764","title":"Study to Evaluate the Overall Performance of the Zalviso System™ (Sufentanil Sublingual Tablet System) 15 mcg","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":320,"lead_sponsor_name":"Talphera, Inc","has_results":true},{"nct_id":"NCT04812860","title":"A Study to Evaluate the Efficacy and Safety of HR18042 Tablets in the Treatment of Postoperative Pain of Impacted Tooth.","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":187,"lead_sponsor_name":"Jiangsu HengRui Medicine Co., Ltd.","has_results":false},{"nct_id":"NCT05096494","title":"Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Scilex Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT02221674","title":"Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":40,"lead_sponsor_name":"Grünenthal GmbH","has_results":true}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}